Ambition
Wiivv, with a mission to disrupt the traditional orthotic market, identified a critical gap: the lack of personalized orthotic solutions catering to individual anatomical differences.
Case study · Wiivv
Wiivv: A visionary enterprise set to revolutionize the orthotic industry with bespoke solutions, built on a belief most of the industry hadn’t questioned: that “custom” and “at scale” couldn’t coexist.
The genesis
Wiivv, with a mission to disrupt the traditional orthotic market, identified a critical gap: the lack of personalized orthotic solutions catering to individual anatomical differences.
A diverse demographic ranging from high-performance athletes to professionals like nurses and doctors who endure prolonged periods on their feet.
The challenge
The market was saturated with generic, one-size-fits-all orthotics, leading to discomfort and suboptimal support.
Despite raising $5 million and generating a buzz with one of the most successful 3D printing Kickstarter campaigns, Wiivv faced a stumbling block: the urgency to fulfill burgeoning pre-orders due to technological limitations.
The belief underneath the barrier: that scaling custom manufacturing meant choosing between speed and precision. It doesn’t have to.
Our strategic intervention
Garnered 5,000 pre-orders, setting the stage for a groundbreaking market entry.
Hired a brilliant team of engineers. Overhauled the cloud infrastructure. Refined the AI models driving the fit engine.
Seamlessly integrated the assembly line operations with the technological advancements for a smooth, scalable pipeline from scan to shipped product.
Execution & innovation
Developed a cutting-edge app enabling users to scan their feet with remarkable precision, creating highly accurate 3D models.
Advanced 3D printing technology transformed these scans into tailor-made orthotics with 0.2mm accuracy.
Filed for pioneering patents, including one for integrating electronic sensors to analyze foot movement and gait, offering users deeper health insights.
Results
Effortlessly delivered the initial pre-orders, overcoming the initial technology hurdle.
Launched new product versions, constantly pushing the boundaries of orthotic customization.
Empirical studies validated the effectiveness of these custom orthotics in pain mitigation and performance enhancement.
Captivated a significant customer base, marking a major milestone in customer reach.
Attracted Bayer, a global powerhouse, leading to a lucrative licensing agreement and rebranding under the prestigious Dr. Scholl’s label.
By the numbers
$2.5 million invested in this transformative project.
An intense 15-month period of technological development, team expansion, and strategic innovations.
Conclusion
Wiivv’s journey stands as proof of what changes when a company stops operating from an inherited belief about what’s possible and starts building from what’s actually true about its own capability. Their belief ceiling lifted, from “custom or scale, pick one” to both, at once, and everything downstream changed: the product, the partnerships, the company’s place in its own industry.
Our collaboration didn’t just resolve a technological challenge. It cleared the belief that was constraining the solution, then built the capacity to act from the new one, culminating in a prestigious partnership with a global industry titan.
In their words
High integrity, incredible resourcefulness, and battle-tested experience are three qualities that TetraNoodle brings to any project or team.
Shamil Hargovan
CEO, Wiivv
TetraNoodle quickly hired a strong team, launched the platform, and scaled it very effectively.
Louis-Victor Jadavji
Cofounder, Wiivv
What’s next
See where you stand, then build the operation that compounds from here.